Skip to content

RNTX RNTX CapEx

Discontinued — last reported Q4 '21

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Gilead Sciences logo
Gilead SciencesGILD
$117M+12.5%
AbbVie logo
AbbVieABBV
$265M+12.8%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$138K
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$178K+45.9%
LQD
Liquidia CorporationLQDA
$2.83M+758%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: RNTX’s 10-K, filed March 20, 2023, on SEC EDGAR. View the filing →

Ask your AI about RNTX's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's capex?
RNTX (RNTX) reported capex of $0 in Q4 2021.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.